Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Men with testicular cancer were less likely to experience baldness and severe acne.

The normal human prostate does not significantly affect blood DHT levels.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.